Bradley L. Campbell, President and CEO: Amicus Therapeutics FOLD Sell · Filed 24/02/20

Trade details

Type: Insider sale
Amount: $58,338
Shares · price: 4,167 sh · $14.00 a share
Held after: 871,219 sh
Stock: Amicus Therapeutics FOLD
Person: Bradley L. CampbellPresident and CEO
Trade date: 24/02/15
Filed: 24/02/20
Days to filing: 5 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Amicus Therapeutics trades, last 26 weeks

What else happened in Amicus Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/16~24/03/16

Bradley L. Campbell's recent trades

Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$322.9K
22,500 sh
$322.9K
Filed 03/04
Traded 03/02
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$1.1M
75,000 sh
$1.1M
Filed 01/22
Traded 01/20
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$846.3K
77,926 sh
$846.3K
Filed 25/12/17
Traded 25/12/15
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146K
14,587 sh
$146K
Filed 25/12/03
Traded 25/12/01
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146.5K
14,587 sh
$146.5K
Filed 25/11/26
Traded 25/11/24